OakChart

Omada Health Inc

OMDAHealthcare·Health Information Services·USA·Small·NASD·Nov 11 • 12:41 PM ET

15.42+0.36 (2.39%)
2026-11-11 18:42 CET
Market cap
934.29 USD m
Revenue, TTM
333.04 USD m
Net income, TTM
14.03 USD m
Free cash flow, TTM
28.15 USD m
EPS diluted, TTM
0.22
P/E
70.64
Compare

Price

OMDA against its 20, 50 and 200-day averages
2050200beat
15.0020.0025.003.4M6.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26OMDAclose 15.4220-day 18.1350-day 19.63200-day 17.7215.4252w high

39.4% under the 52-week high of 25.45 on 27 Aug 2026. 52-week low 10.28 on 11 Feb 2026. Last 15 sessions, 39.0% high to low

Profile

OMDA
52-week range, 34% of the way up
10.2825.45

Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy in 2011 and is headquartered in South San Francisco, CA.

IndexRUT
Employees916
IPOJun 06, 2025
Beta2.31
ATR, 14d1.17
Rel volume0.63
Short float18.18%
Insider own18.75%
Inst own76.86%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap956.62M
Enterprise Value713.47M
Income14.03M
Sales333.04M
Book/sh4.41
Cash/sh3.92
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees916
IPOJun 06, 2025

Ratios

P/E70.64
Forward P/E26.33
PEG-
P/S2.87
P/B3.50
P/C3.93
P/FCF33.98
EV/EBITDA54.51
EV/Sales2.14
Quick Ratio4.06
Current Ratio4.13
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)0.22
EPS next Y0.59
EPS next Q0.12
EPS this Y239.57%
EPS next Y19.87%
EPS next 5Y-
EPS past 3/5Y44.81% -
Sales past 3/5Y42.89% -
EPS Y/Y TTM150.13%
Sales Y/Y TTM43.34%
EPS Q/Q277.78%
Sales Q/Q34.21%
EarningsNov 05 AMC
EPS/Sales Surpr.29.68% 6.61%

Ownership

Insider Own18.75%
Insider Trans-2.95%
Inst Own76.86%
Inst Trans-0.61%
ROA4.41%
ROE5.72%
ROIC5.14%
Gross Margin70.58%
Oper. Margin2.06%
Profit Margin4.21%
SMA20-14.94%
SMA50-21.46%
SMA200-12.98%
Trades-

Technical

Shs Outstand62.00M
Shs Float50.41M
Short Float18.18%
Short Ratio7.05
Short Interest9.16M
52W High25.45 -39.41%
52W Low10.28 50.00%
Volatility6.94% 6.13%
ATR (14)1.17
RSI (14)33.91
Beta2.31
Rel Volume0.63
Avg Volume1.30M
Volume421,592

Performance

Perf Week-20.64%
Perf Month-15.74%
Perf Quarter-36.73%
Perf Half Y-3.87%
Perf YTD-2.28%
Perf Year-25.90%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.42
Target Price26.92
Prev Close15.06
Price15.42
Change %2.39%

Analyst ratings

latest 10 of 12
DateActionAnalystRating changeTargetImplied
Jul 17, 2026InitiatedBBTIG ResearchBuy$30+94.6%
Apr 14, 2026InitiatedCCitizensMkt Outperform$18+16.7%
Jan 09, 2026InitiatedWWells FargoEqual Weight$17+10.2%
Nov 13, 2025InitiatedBBMO Capital MarketsOutperform$27+75.1%
Sep 05, 2025InitiatedRRobert W. BairdNeutral$24+55.6%
Jul 01, 2025InitiatedNNeedhamBuy$23+49.2%
Jul 01, 2025InitiatedMMorgan StanleyOverweight$25+62.1%
Jul 01, 2025InitiatedJJP MorganOverweight$19+23.2%
Jul 01, 2025InitiatedGGoldmanBuy$29+88.1%
Jul 01, 2025InitiatedEEvercore ISIOutperform$21+36.2%

Peers

Mkt cap
TickerCompanyMkt cap
TDOCTeladoc Health Inc1.65B
HNGEHinge Health Inc9.58B
DRIODarioHealth Corp25.53M
AMWLAmerican Well Corp211.81M
LFMDLifeMD Inc80.50M
EVHEvolent Health Inc553.10M
WWWW International Inc130.87M
PGNYProgyny Inc2.65B
HIMSHims & Hers Health Inc4.76B
HQYHealthequity Inc8.46B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Duffy Sean P.Chief Executive OfficerNov 04 '26Option Exercise5.8212,94475,334395,538Nov 06 04:38 PM
Duffy Sean P.Chief Executive OfficerNov 04 '26Sale19.2212,944248,731382,594Nov 06 04:38 PM
SEAN DUFFYDirectorNov 04 '26Proposed Sale18.5812,944240,500Nov 04 04:23 PM
Duffy Sean P.Chief Executive OfficerOct 01 '26Option Exercise6.4317,258111,054399,852Oct 05 05:06 PM
Duffy Sean P.Chief Executive OfficerOct 01 '26Sale20.6817,258356,915382,594Oct 05 05:06 PM
SEAN DUFFYDirectorOct 01 '26Proposed Sale15.6117,258269,365Oct 01 04:21 PM
Duffy Sean P.Chief Executive OfficerSep 10 '26Sale21.8714,960327,197382,594Sep 14 05:13 PM
Cook Steven L.Chief Financial OfficerSep 10 '26Sale21.866,800148,640173,906Sep 14 05:12 PM
Shao Wei-LiPresidentSep 10 '26Sale21.854,03688,206295,313Sep 14 05:11 PM
Gracey CraigChief Accounting OfficerSep 09 '26Sale21.7364413,99514,412Sep 11 04:45 PM
Steven CookOfficerSep 10 '26Proposed Sale21.506,800146,200Sep 10 05:17 PM
WEI-LI SHAOOfficerSep 10 '26Proposed Sale21.504,03686,774Sep 10 05:17 PM
SEAN DUFFYDirectorSep 10 '26Proposed Sale21.5014,960321,640Sep 10 04:41 PM
CRAIG GRACEYOfficerSep 09 '26Proposed Sale22.1864414,284Sep 09 04:22 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
XHSState Street SPDR S&P Health Care Services ETFAUM: 246.09M
VHTVanguard Health Care ETFAUM: 21.51B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B

News

latest 14 of 126
  • Unusual Options Volume Report: 3 Stocks Moving After Earnings (Schaeffer's Research) -20.37%
  • Omada Health Beats Consensus But Misses The Whisper As Third Guidance Raise Collides With Slowing Growth And A Cloudier 2027 (Earnings Whispers)
  • Omada Health Reports Third Quarter 2026 Results (GlobeNewswire)
  • After Two Guidance Raises, Omada Must Prove Its Second-Half Slowdown Is Only By Design (Earnings Whispers)
  • Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress (GlobeNewswire) +7.09%
  • Loading…
  • Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026 (GlobeNewswire) -16.32%
  • Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day (GlobeNewswire)
  • Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program (GlobeNewswire)
  • Earnings To Watch: Omda AS (OSL:OMDA) Q2 2026 -- GF Value Sees 32% Upside (GuruFocus.com)
  • Omada Health Inc (OMDA) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability ... (GuruFocus.com) +21.14%
  • Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition (GlobeNewswire)
  • UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026 (GlobeNewswire)
  • Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on August 6, 2026 (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.0900.0690.09891.3185.657
2026Q22026-08-060.1650.0620.08387.8480.045
2026Q12026-05-070.040-0.128-0.05078.0574.094
2025Q42026-03-050.0800.0090.08875.8570.219
2025Q32025-11-06-0.060-0.079-0.05568.0361.288
2025Q22025-08-07-0.240-0.118-0.09361.3755.336
2025Q12025-05-28-0.198--0.17054.98--
2026Q4--0.118--87.546
2027Q1--0.023--95.124
2027Q2--0.146--102.924
2027Q3--0.177--106.784
2027Q4--0.159--104.824
2028Q1--0.050--116.141
2028Q2--0.140--1221
2028Q3--0.170--125.371
2028Q4--0.160--121.751

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-0.350-0.027-0.350260.21253.94
2026FY-0.489--343.79
2027FY-0.586--411.46
2028FY-0.965--487.35

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-06104287.5486.0088.69
2026Q4S2026-11-05100187.0385.5992.48
2026Q4S2026-10-27100187.0385.5992.48
2026Q4S2026-10-21102187.0385.5992.48
2026Q4S2026-10-02104387.0385.5992.48
2026Q4S2026-09-28104287.1485.5992.48
2026Q4S2026-09-14104287.1385.5692.48
2026Q4S2026-09-11104287.1485.5692.48
2026Q4S2026-09-10104287.1385.5692.48
2026Q4S2026-08-13104187.1785.5692.48
2026Q4S2026-08-11102186.9685.0092.48
2026Q4S2026-08-07102186.9085.0092.48
2026Q4S2026-07-28100086.7684.2192.48
2026Q4S2026-07-26101086.7684.2192.48

Estimate history

EPS, annual-1.301-1.211-0.846-0.2190.2183
Period2022202320242025TTM
EPS, quarterly-0.166-0.148-0.17-0.093-0.0550.088-0.050.0830.098
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual89.185122.784169.8260.21333.04
Period2022202320242025TTM
Sales, quarterly45.51547.97854.96361.37168.0375.84678.04887.83591.306
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual55.74455.74455.74458.42961.996
Period2022202320242025MRQ
Shares, quarterly55.74455.74455.74457.32157.88758.42959.2460.60661.996
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Total Revenue333.04260.21169.80122.7889.19
Cost of Goods Sold Incl. D&A97.9789.7167.5653.4947.16
Gross Profit235.06170.50102.2369.2942.03
Selling, General and Administrative Excl. Other228.19182.47145.89135.29114.38
Research and Development54.0240.5935.8433.6626.09
Other Operating Expense0.000.000.000.000.00
Operating Income6.87-11.97-43.65-66.00-72.35
Interest Expense0.312.534.514.714.20
Unusual Expense-3.58-0.222.58-1.83
Net Income Before Taxes14.03-12.78-47.14-67.51-72.52
Income Taxes0.000.000.000.000.00
Consolidated Net Income14.03-12.78-47.14-67.51-72.52
Net Income From Continuing Operations14.03-12.78-47.14-67.51-72.52
Net Income14.03-12.78-47.14-67.51-72.52
EPS (Recurring)0.21-0.18-0.85-1.18-1.32
EPS (Basic, Before Extraordinaries)0.23-0.22-0.85-1.21-1.30
EPS (Diluted)0.22-0.22-0.85-1.21-1.30
EBITDA13.09-6.48-38.85-61.55-68.02
Non-Operating Income (Expense)7.475.300.815.782.20
Other After Tax Adjustments0.000.000.000.000.00
Stock Option Compensation Expense19.4412.969.428.746.65
Price To Earnings Ratio68.9968.99---
Price To Sales Ratio4.193.54---
Gross Margin70.5865.5260.2156.4347.13
Operating Margin2.06-4.60-25.71-53.75-81.12
Net Margin4.21-4.91-27.76-54.98-81.31
Shares Outstanding62.0058.4355.7455.7455.74
Market Capitalization934.29934.29888.31--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue91.3187.8378.0575.8568.0361.3754.9647.98
Cost of Goods Sold Incl. D&A22.1324.1429.4422.2623.0421.1923.2216.00
Gross Profit69.1863.7048.6053.5844.9940.1831.7531.98
Selling, General and Administrative Excl. Other64.3660.1553.3850.3047.5044.5240.1439.08
Research and Development15.2314.5912.6611.5310.2810.008.799.17
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income4.823.55-4.783.28-2.51-4.34-8.40-7.10
Interest Expense0.260.010.020.010.351.091.071.10
Unusual Expense0.000.00-0.002.320.740.520.23
Net Income Before Taxes6.555.29-2.975.16-3.18-5.31-9.45-8.25
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income6.555.29-2.975.16-3.18-5.31-9.45-8.25
Net Income From Continuing Operations6.555.29-2.975.16-3.18-5.31-9.45-8.25
Net Income6.555.29-2.975.16-3.18-5.31-9.45-8.25
EPS (Recurring)0.100.08-0.050.09-0.03-0.08-0.16-0.15
EPS (Basic, Before Extraordinaries)0.110.09-0.050.09-0.05-0.09-0.17-0.15
EPS (Diluted)0.100.08-0.050.09-0.05-0.09-0.17-0.15
EBITDA6.505.13-3.274.73-1.15-2.99-7.06-5.82
Non-Operating Income (Expense)1.991.761.831.892.010.860.540.17
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.855.634.213.753.542.832.842.31
Price To Earnings Ratio68.99-------
Price To Sales Ratio4.194.532.613.545.515.00--
Gross Margin75.7772.5262.2770.6566.1365.4757.7666.65
Operating Margin5.284.04-6.134.33-3.69-7.08-15.28-14.80
Net Margin7.176.03-3.816.80-4.67-8.65-17.19-17.19
Shares Outstanding62.0060.6159.2458.4357.8957.3255.7455.74
Market Capitalization934.291,304.89740.69913.791,272.981,020.12981.66-

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY
Cash & Short Term Investments222.0476.39115.64168.12
Short Term Receivables35.2223.9216.4411.67
Inventories4.493.303.613.54
Other Current Assets7.656.435.023.41
Total Current Assets269.39110.04140.71186.74
Net Property, Plant & Equipment7.946.075.606.06
Total Investments and Advances0.000.000.000.00
Intangible Assets15.6517.5019.5121.55
Other Assets12.4117.279.267.44
Total Assets305.41150.89175.08221.80
Short Term Debt Incl. Current Port. of LT Debt0.000.410.790.65
Accounts Payable10.284.173.624.11
Other Current Liabilities65.4549.3739.3829.76
Total Current Liabilities75.7353.9543.7934.51
Long Term Debt0.0029.7729.7930.16
Provision for Risks Charges0.000.000.000.00
Other Liabilities0.002.542.581.52
Total Liabilities75.7386.2676.1666.19
Non-Equity Reserves0.000.000.000.00
Preferred Stock - Carrying Value0.00449.03449.03448.78
Common Equity229.68-384.40-350.11-293.17
Total Shareholders Equity229.6864.6398.92155.60
Accumulated Minority Interest0.000.000.000.00
Total Equity229.6864.6398.92155.60
Total Liabilities & Stockholders Equity305.41150.89175.08221.80
Book Value Per Share3.93-6.90-6.28-5.26
Tangible Book Value Per Share3.66-7.21-6.63-5.65
Full-Time Employees916849--
Price to Book Ratio3.424.09--
Return on Assets-5.60-28.92-34.02-
Return on Equity-8.68-57.64-53.05-
Return on Invested Capital-5.56-49.93-52.45-39.04
Quick Ratio3.501.983.135.31
Current Ratio3.562.043.215.41

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Net Income14.03-12.78-47.14-67.51-72.52
Depreciation6.225.494.804.454.33
Other Funds (Non Cash)25.2921.8014.7214.828.35
Funds from Operations45.5414.51-27.61-48.24-59.84
Extraordinary Item0.000.000.000.000.00
Changes in Working Capital-16.843.74-6.57-1.50-7.87
Cash from Operating Activities28.6918.25-34.18-49.74-67.71
Capital Expenditures-6.20-5.83-3.86-2.92-2.72
Net Assets From Acquisitions0.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.00
Purchase of Investments0.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.00
Other Uses0.000.000.000.000.00
Other Sources0.000.000.000.000.00
Cash from Investing Activities-6.20-5.83-3.86-2.92-2.72
Cash Dividends Paid0.000.000.000.000.00
Change in Capital Stock23.36169.903.331.751.74
Repurchase of Common Pref Stock0.000.000.000.000.00
Sale of Common Pref Stock23.36169.903.331.751.74
Proceedsfrom Stock Options0.00160.533.331.751.74
Issuance or Reduction of Debt, Net1.43-30.960.00-1.47-1.27
Change in Long Term Debt1.43-30.960.00-1.470.00
Issuance of Long Term Debt0.000.000.0028.540.00
Reduction of Long Term Debt1.43-30.960.00-30.000.00
Net Financing Active Other Cash Flow-2.76-5.71-4.54-0.1114.58
Other Financing Activities Uses-2.76-5.71-4.54-0.110.00
Cash from Financing Activities22.03133.22-1.210.1815.05
Net Change in Cash44.52145.64-39.25-52.48-55.38
Free Cash Flow28.1516.93-34.77-50.15-68.43
Preferred Dividends (Cash Flow)-0.000.000.000.00
Price to Free Cash Flow49.6254.46---
Deferred Taxes & Investment Tax Credit-0.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments243.15221.71211.76222.04198.63223.15
Short Term Receivables48.9957.5741.3835.2242.2533.29
Inventories4.884.123.834.493.153.47
Other Current Assets14.097.558.437.657.657.75
Total Current Assets311.11290.95265.41269.39251.67267.65
Net Property, Plant & Equipment9.749.108.467.947.546.55
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets14.3414.7815.2115.6516.0916.53
Other Assets13.3513.4013.7212.4112.1712.24
Total Assets348.54328.22302.80305.41287.47302.97
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable8.3811.808.1010.285.347.40
Other Current Liabilities66.9963.6860.5865.4564.7850.59
Total Current Liabilities75.3875.4868.6875.7370.1257.99
Long Term Debt0.000.000.000.000.0029.97
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.80
Total Liabilities75.3875.4868.6875.7370.1288.76
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity273.16252.74234.12229.68217.35214.21
Total Shareholders Equity273.16252.74234.12229.68217.35214.21
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity273.16252.74234.12229.68217.35214.21
Total Liabilities & Stockholders Equity348.54328.22302.80305.41287.47302.97
Book Value Per Share4.414.173.953.933.753.74
Tangible Book Value Per Share4.173.933.703.663.483.45
Full-Time Employees980--916868-
Price to Book Ratio3.425.553.204.205.92-2.62
Return on Assets4.411.36-2.84---
Return on Equity5.721.84-4.30---
Return on Invested Capital2.402.09-1.272.25-1.46-2.18
Quick Ratio4.063.803.813.503.544.56
Current Ratio4.133.853.863.563.594.62

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income6.555.29-2.975.16-3.18-5.31
Depreciation1.681.581.511.451.361.35
Other Funds (Non Cash)7.987.015.974.337.864.59
Funds from Operations16.2113.884.5110.936.040.63
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.07-9.88-16.3510.454.102.23
Cash from Operating Activities15.144.01-11.8321.3810.132.86
Capital Expenditures-1.63-1.66-1.56-1.35-1.99-1.25
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-1.63-1.66-1.56-1.35-1.99-1.25
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock8.608.143.253.382.08163.52
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock8.608.143.253.382.08163.52
Proceedsfrom Stock Options0.000.000.000.000.00159.61
Issuance or Reduction of Debt, Net0.000.000.001.43-32.390.00
Change in Long Term Debt0.000.000.001.43-32.390.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.001.43-32.390.00
Net Financing Active Other Cash Flow-0.67-0.53-0.13-1.43-2.36-1.38
Other Financing Activities Uses-0.67-0.53-0.13-1.43-2.36-1.38
Cash from Financing Activities7.937.603.123.38-32.66162.14
Net Change in Cash21.449.95-10.2723.41-24.52163.75
Free Cash Flow15.023.86-11.9121.189.602.59
Price to Free Cash Flow49.6261.7734.5354.46--

Revenue breakdown

Hardware2024: 12.01M 2025: 19.17M
Service2024: 157.79M 2025: 241.04M
United States2024: 169.80M 2025: 260.21M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3018.42%9.2M49.7M1.32M
2026-10-1516.78%8.3M49.7M1.41M
2026-09-3014.98%7.5M49.7M1.40M
2026-09-1523.87%7.5M31.3M1.32M
2026-08-3119.08%5.7M30.1M1.27M
2026-08-1419.57%5.9M30.1M1.28M
2026-07-3127.38%7.6M27.9M1.24M
2026-07-1528.93%8.0M27.6M1.13M
2026-06-3028.13%7.8M27.7M1.05M
2026-06-1528.24%7.8M27.6M1.09M
2026-05-2925.07%7.0M27.9M1.29M
2026-05-1521.74%6.1M28.0M1.33M
2026-04-3017.31%4.2M24.4M1.28M
2026-04-1515.01%3.7M24.4M1.35M
2026-03-3113.89%3.5M25.5M1.39M
2026-03-1311.15%2.8M25.5M1.28M
2026-02-2714.37%3.6M25.1M1.20M
2026-02-1311.94%3.0M25.1M1.11M
2026-01-3010.92%2.6M23.8M1.02M
2026-01-156.29%1.5M23.8M867.55K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5011.5014.200.0015.4920.000.000.992-0.0170.001
call5.008.6011.900.0010.0160.000.000.951-0.0820.002
call7.506.009.700.007.3550.000.000.924-0.0790.003
call10.004.605.800.002.7820.000.000.886-0.0720.005
call12.502.203.403.201.7781.000.000.806-0.0690.007
call15.000.451.200.571.0751.000.000.593-0.0460.009
call17.500.000.750.051.5583850.000.341-0.0770.009
call20.000.001.000.072.1851,3470.000.274-0.0980.008
call22.500.000.950.062.6681010.000.240-0.1110.007
call25.000.000.350.102.43048.000.000.138-0.0720.005
call30.000.000.050.033.6982.000.000.195-0.1360.007
call35.000.000.950.002.4400.000.000.025-0.0190.001
call40.000.000.950.002.7510.000.000.023-0.0200.001
put2.500.000.050.005.6150.000.00-0.008-0.0150.001
put5.000.001.250.006.0420.000.00-0.049-0.0820.002
put7.500.001.950.004.1010.000.00-0.076-0.0780.003
put10.000.000.450.002.7720.000.00-0.113-0.0710.005
put12.500.001.100.001.8350.000.00-0.195-0.0670.007
put15.000.400.550.490.7611023.00-0.402-0.0440.009
put17.501.802.902.871.5782300.00-0.659-0.0750.009
put20.004.205.404.962.22147.000.00-0.726-0.0950.008
put22.505.808.703.993.6842.000.00-0.759-0.1090.008
put25.008.8010.704.053.5176.000.00-0.862-0.0690.005
put30.0013.3016.200.004.8320.000.00-0.971-0.0150.002
put35.0017.7021.500.005.6040.000.00-0.975-0.0160.001
put40.0023.3026.500.006.1520.000.00-0.977-0.0160.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-05SCHEDULE 13G/ASEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02SCHEDULE 13G/ASEC
2026-10-27SCHEDULE 13GSEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-09-09144Filing for proposed sale of securities under Rule 144.SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-05SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-05SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-05SEC
2026-09-044/A2026-08-12SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100248.73K1
2026-1000356.92K1
2026-09001.09M5
2026-08001.47M8
2026-07001.87M7
2026-06002.51M18
2026-050000
2026-040035.95K1
2026-030084.54K2
2026-020000
2026-01004.25M2
2025-1200297.73K3
2025-110000

Institutional holders

Manager% owned
Revelation Capital Management, LLC8.17%
Divisadero Street Capital Management, LP6.39%
AMERICAN CENTURY COMPANIES INC6.19%
CIGNA INVESTMENTS INC /NEW5.63%
MORGAN STANLEY4.71%
FMR LLC4.56%
NVP Associates, LLC4.26%
BlackRock, Inc.3.74%
VANGUARD CAPITAL MANAGEMENT LLC3.24%
MILLENNIUM MANAGEMENT LLC2.90%

Funds

Fund% owned
Small Cap Growth Fund4.73%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.99%
Oberweis Micro-Cap Fund1.70%
Fidelity Growth Company Fund1.65%
iShares Russell 2000 ETF1.55%
Loomis Sayles Small Cap Growth Fund1.46%
Nuveen Quant Small Cap Equity Fund0.82%
Fidelity Small Cap Index Fund0.66%
iShares Russell 2000 Growth ETF0.54%
Small Cap Growth Fund0.45%

OakChart. OMDA. Cached 15 minutes.